Study on slow-release of indomethacin from suppositories containing hydrogenated soybean lecithin. 1988

T Nakajima, and Y Takashima, and A Furuya, and Y Ozawa, and Y Kawashima

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D006865 Hydrogenation Addition of hydrogen to a compound, especially to an unsaturated fat or fatty acid. (From Stedman, 26th ed) Hydrogenations
D013025 Glycine max An annual legume. The SEEDS of this plant are edible and used to produce a variety of SOY FOODS. Soy Beans,Soybeans,Bean, Soy,Beans, Soy,Soy Bean,Soybean
D013488 Suppositories Medicated dosage forms that are designed to be inserted into the rectal, vaginal, or urethral orifice of the body for absorption. Generally, the active ingredients are packaged in dosage forms containing fatty bases such as cocoa butter, hydrogenated oil, or glycerogelatin that are solid at room temperature but melt or dissolve at body temperature. Rectal Suppositories,Vaginal Suppositories,Vaginal Suppository,Suppositories, Rectal,Suppositories, Vaginal,Suppository, Vaginal

Related Publications

T Nakajima, and Y Takashima, and A Furuya, and Y Ozawa, and Y Kawashima
April 1981, The New Zealand medical journal,
T Nakajima, and Y Takashima, and A Furuya, and Y Ozawa, and Y Kawashima
January 2008, Indian journal of pharmaceutical sciences,
T Nakajima, and Y Takashima, and A Furuya, and Y Ozawa, and Y Kawashima
October 1985, Die Pharmazie,
T Nakajima, and Y Takashima, and A Furuya, and Y Ozawa, and Y Kawashima
June 2012, Journal of colloid and interface science,
T Nakajima, and Y Takashima, and A Furuya, and Y Ozawa, and Y Kawashima
February 1988, Chemical & pharmaceutical bulletin,
T Nakajima, and Y Takashima, and A Furuya, and Y Ozawa, and Y Kawashima
February 1991, Acta medica Okayama,
T Nakajima, and Y Takashima, and A Furuya, and Y Ozawa, and Y Kawashima
January 2001, International journal of toxicology,
T Nakajima, and Y Takashima, and A Furuya, and Y Ozawa, and Y Kawashima
August 1983, Chemical & pharmaceutical bulletin,
T Nakajima, and Y Takashima, and A Furuya, and Y Ozawa, and Y Kawashima
March 1985, Pharmaceutical research,
T Nakajima, and Y Takashima, and A Furuya, and Y Ozawa, and Y Kawashima
December 1988, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!